Interesting Histogen info

Stem cell; cell based hair therapy
21

» Vavelta high-dose gave poorer results than low-dose.
»
» Its not so easy. More dosing doesn’t always mean more results.
»
» It seems that Histogen is repeating ICX’ steps to disaster. I hope I am
» wrong.
» But lack of investors speaks for itself.

Lack of investors does not speak for itself. ICX had poor management and little funding. The funding problems were NOT a result of the quality of the technology. They lacked money to fund their trials. And how can you determine whether the technology is good or not without trials? So investors must invest BEFORE they know the quality of the technology.

22

» You have to love America’s priorities.
» You can have a gun today, but your medicine is always 5+ years away.

Guns were invented hundreds of years ago, and medicine is not always 5+ years away, otherwise we wouldn’t have ANY!

23

» They are not saying 5 years. They are targeting 2015 and have been for
» the last several years.

And they’ve also narrowed down their timeline. It used to be 2015-2018. Now it’s 2015 or before!

24

» That’s some pretty good spin! If you’re not already on Histogen’s
» payroll, you should be!!

You tell me. Does being a shill pay well?